Derek M. Erion

7.1k total citations · 5 hit papers
40 papers, 5.2k citations indexed

About

Derek M. Erion is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Derek M. Erion has authored 40 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 15 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Physiology. Recurrent topics in Derek M. Erion's work include Liver Disease Diagnosis and Treatment (14 papers), Adipose Tissue and Metabolism (11 papers) and Diet, Metabolism, and Disease (10 papers). Derek M. Erion is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Adipose Tissue and Metabolism (11 papers) and Diet, Metabolism, and Disease (10 papers). Derek M. Erion collaborates with scholars based in United States, Japan and Canada. Derek M. Erion's co-authors include Gerald I. Shulman, Varman T. Samuel, Gary W. Cline, Sanjay Bhanot, Tamás L. Horváth, Hui‐Young Lee, Nicholas B. Vera, Zane B. Andrews, Michael J. Jurczak and Matthew P. Gillum and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Derek M. Erion

40 papers receiving 5.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

2014 961 citations Anila K. Madiraju, Derek M. Erion et al. Nature profile →
UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals

2008 579 citations Zane B. Andrews, Liu Hon et al. Nature profile →
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease

2011 450 citations Naoki Kumashiro, Derek M. Erion et al. profile →
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects

2016 406 citations Saswata Talukdar, Yingjiang Zhou et al. Cell Metabolism profile →
Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice

2015 361 citations Derek M. Erion, Nicholas B. Vera et al. Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Derek M. Erion United States	27	2.4k	1.9k	1.6k	1.3k	989	40	5.2k
Renaud Dentin France	24	2.5k 1.1×	1.4k 0.7×	1.5k 0.9×	1.2k 0.9×	1.5k 1.5×	34	5.1k
Sandra Galić Australia	33	3.3k 1.4×	1.9k 1.0×	1.6k 1.0×	734 0.6×	1.1k 1.1×	54	6.0k
Katsutaro Morino Japan	33	2.5k 1.0×	2.4k 1.3×	1.4k 0.9×	863 0.7×	699 0.7×	99	5.3k
Bingzhong Xue United States	37	2.6k 1.1×	3.2k 1.7×	1.6k 1.0×	675 0.5×	959 1.0×	87	6.6k
Jennifer L. Estall Canada	31	2.8k 1.2×	2.9k 1.6×	1.8k 1.1×	904 0.7×	978 1.0×	51	5.9k
Saswata Talukdar United States	32	3.2k 1.3×	2.3k 1.2×	2.5k 1.6×	1.1k 0.8×	1.1k 1.1×	48	7.3k
Brice Emanuelli Denmark	20	2.6k 1.1×	1.8k 1.0×	1.3k 0.8×	746 0.6×	671 0.7×	36	5.0k
Sofianos Andrikopoulos Australia	38	2.1k 0.9×	1.8k 0.9×	823 0.5×	1.1k 0.9×	1.2k 1.2×	103	5.0k
Bei B. Zhang United States	38	3.9k 1.6×	2.9k 1.5×	2.1k 1.3×	2.3k 1.7×	2.2k 2.2×	68	8.6k
Fabrizio Andréelli France	28	4.7k 1.9×	2.5k 1.3×	1.1k 0.7×	1.7k 1.3×	2.6k 2.6×	88	7.2k

Countries citing papers authored by Derek M. Erion

Since Specialization

Citations

This map shows the geographic impact of Derek M. Erion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek M. Erion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek M. Erion more than expected).

Fields of papers citing papers by Derek M. Erion

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek M. Erion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek M. Erion. The network helps show where Derek M. Erion may publish in the future.

Co-authorship network of co-authors of Derek M. Erion

This figure shows the co-authorship network connecting the top 25 collaborators of Derek M. Erion. A scholar is included among the top collaborators of Derek M. Erion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek M. Erion. Derek M. Erion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Erion, Derek M., et al.. (2024). Editing Approaches to Treat Alpha-1 Antitrypsin Deficiency. CHEST Journal. 167(2). 444–452. 9 indexed citations

Toft, P, Hiroaki Yashiro, Derek M. Erion, et al.. (2023). Microbial dietary protein metabolism regulates GLP ‐1 mediated intestinal transit. The FASEB Journal. 37(10). e23201–e23201. 2 indexed citations

Li, Min‐Dian, Nicholas B. Vera, Yunfan Yang, et al.. (2018). Adipocyte OGT governs diet-induced hyperphagia and obesity. Nature Communications. 9(1). 5103–5103. 53 indexed citations

Mottillo, Emilio P., Eric M. Desjardins, Andreas M. Fritzen, et al.. (2017). FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis. Molecular Metabolism. 6(6). 471–481. 49 indexed citations

Pajor, Ana M., et al.. (2016). Molecular Basis for Inhibition of the Na+/Citrate Transporter NaCT (SLC13A5) by Dicarboxylate Inhibitors. Molecular Pharmacology. 90(6). 755–765. 23 indexed citations

Erion, Derek M., Hyun‐Jun Park, & Hui‐Young Lee. (2016). The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities. BMB Reports. 49(3). 139–148. 63 indexed citations

Riccardi, Keith, Zhongrui Li, Janice A. Brown, et al.. (2016). Determination of Unbound Partition Coefficient and in Vitro–in Vivo Extrapolation for SLC13A Transporter–Mediated Uptake. Drug Metabolism and Disposition. 44(10). 1633–1642. 23 indexed citations

Talukdar, Saswata, Yingjiang Zhou, Dongmei Li, et al.. (2016). A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects. Cell Metabolism. 23(3). 427–440. 406 indexed citations breakdown →

Clark, Ronald W., Nicholas B. Vera, Kou Kou, et al.. (2015). Characterization of a Novel Intestinal Glycerol-3-phosphate Acyltransferase Pathway and Its Role in Lipid Homeostasis. Journal of Biological Chemistry. 291(6). 2602–2615. 29 indexed citations

10.

Madiraju, Anila K., Derek M. Erion, Yasmeen Rahimi, et al.. (2014). Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 510(7506). 542–546. 961 indexed citations breakdown →

11.

Erion, Derek M., Maya E. Kotas, Shin Yonemitsu, et al.. (2013). cAMP-responsive Element-binding Protein (CREB)-regulated Transcription Coactivator 2 (CRTC2) Promotes Glucagon Clearance and Hepatic Amino Acid Catabolism to Regulate Glucose Homeostasis. Journal of Biological Chemistry. 288(22). 16167–16176. 18 indexed citations

12.

Kumashiro, Naoki, Toru Yoshimura, Jennifer Cantley, et al.. (2012). Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats. Hepatology. 57(5). 1763–1772. 75 indexed citations

13.

Erion, Derek M., Jennifer J. Hsiao, Daniel F. Vatner, et al.. (2012). The Role of the Carbohydrate Response Element-Binding Protein in Male Fructose-Fed Rats. Endocrinology. 154(1). 36–44. 62 indexed citations

14.

Gillum, Matthew P., Maya E. Kotas, Derek M. Erion, et al.. (2011). SirT1 Regulates Adipose Tissue Inflammation. Diabetes. 60(12). 3235–3245. 239 indexed citations

15.

Gillum, Matthew P., Derek M. Erion, & Gerald I. Shulman. (2010). Sirtuin-1 regulation of mammalian metabolism. Trends in Molecular Medicine. 17(1). 8–13. 89 indexed citations

16.

Andrews, Zane B., Derek M. Erion, Rudolph J. Beiler, et al.. (2009). Ghrelin Promotes and Protects Nigrostriatal Dopamine Function via a UCP2-Dependent Mitochondrial Mechanism. Journal of Neuroscience. 29(45). 14057–14065. 233 indexed citations

17.

Nagai, Yoshio, Shin Yonemitsu, Derek M. Erion, et al.. (2009). The Role of Peroxisome Proliferator-Activated Receptor γ Coactivator-1 β in the Pathogenesis of Fructose-Induced Insulin Resistance. Cell Metabolism. 9(3). 252–264. 174 indexed citations

18.

Erion, Derek M., Shin Yonemitsu, Yoshio Nagai, et al.. (2009). Prevention of Hepatic Steatosis and Hepatic Insulin Resistance by Knockdown of cAMP Response Element-Binding Protein. Cell Metabolism. 10(6). 499–506. 90 indexed citations

19.

Andrews, Zane B., Liu Hon, Derek M. Erion, et al.. (2008). UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals. Nature. 454(7206). 846–851. 579 indexed citations breakdown →

20.

Gillum, Matthew P., Dongyan Zhang, Xian‐Man Zhang, et al.. (2008). N-acylphosphatidylethanolamine, a Gut- Derived Circulating Factor Induced by Fat Ingestion, Inhibits Food Intake. Cell. 135(5). 813–824. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact